Literature DB >> 18634614

Mast cells can contribute to axon-glial dissociation and fibrosis in peripheral nerve.

Kelly R Monk1, Jianqiang Wu, Jon P Williams, Brenda A Finney, Maureen E Fitzgerald, Marie-Dominique Filippi, Nancy Ratner.   

Abstract

Expression of the human epidermal growth factor receptor (EGFR) in murine Schwann cells results in loss of axon-Schwann cell interactions and collagen deposition, modeling peripheral nerve response to injury and tumorigenesis. Mast cells infiltrate nerves in all three situations. We show that mast cells are present in normal mouse peripheral nerve beginning at 4 weeks of age, and that the number of mast-cells in EGFR(+) nerves increases abruptly at 5-6 weeks of age as axons and Schwann cells dissociate. The increase in mast cell number is preceded and accompanied by elevated levels of mRNAs encoding the mast-cell chemoattractants Rantes, SCF and VEGF. Genetic ablation of mast cells and bone marrow reconstitution in W(41) x EGFR(+) mice indicate a role for mast cells in loss of axon-Schwann cell interactions and collagen deposition. Pharmacological stabilization of mast cells by disodium cromoglycate administration to EGFR(+) mice also diminished loss of axon-Schwann cell interaction. Together these three lines of evidence support the hypothesis that mast cells can contribute to alterations in peripheral nerves.

Entities:  

Year:  2007        PMID: 18634614      PMCID: PMC2561270          DOI: 10.1017/S1740925X08000021

Source DB:  PubMed          Journal:  Neuron Glia Biol        ISSN: 1740-925X


  43 in total

1.  Cancer: an inflammatory link.

Authors:  Fran Balkwill; Lisa M Coussens
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

2.  Mast cells--their presence and ultrastructural characteristics in peripheral nerve tumors.

Authors:  A Pineda
Journal:  Arch Neurol       Date:  1965-10

3.  Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen.

Authors:  V M Riccardi
Journal:  Arch Dermatol       Date:  1987-08

4.  Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

Authors:  J E DeClue; S Heffelfinger; G Benvenuto; B Ling; S Li; W Rui; W C Vass; D Viskochil; N Ratner
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

5.  Disodium cromoglycate in immunological mast cell degranulation of mice: an experimental study.

Authors:  M B Goldgraber
Journal:  Ann Allergy       Date:  1976-08

6.  Mast cells synthesize, store, and release nerve growth factor.

Authors:  A Leon; A Buriani; R Dal Toso; M Fabris; S Romanello; L Aloe; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Molecular cloning and characterization of rat brain 2',3'-cyclic nucleotide 3'-phosphodiesterase isoform 2.

Authors:  M Gravel; D DeAngelis; P E Braun
Journal:  J Neurosci Res       Date:  1994-06-15       Impact factor: 4.164

8.  Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course.

Authors:  Melinda B Tanzola; Michaela Robbie-Ryan; Claire Anne Gutekunst; Melissa A Brown
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

9.  Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. I. Influence upon hematopoietic stem cells.

Authors:  E N Geissler; E S Russell
Journal:  Exp Hematol       Date:  1983-07       Impact factor: 3.084

10.  Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model.

Authors:  Hongzhen Li; Susana Velasco-Miguel; William C Vass; Luis F Parada; Jeffrey E DeClue
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

View more
  13 in total

1.  Back to the future: proceedings from the 2010 NF Conference.

Authors:  Susan M Huson; Maria T Acosta; Allan J Belzberg; Andre Bernards; Jonathan Chernoff; Karen Cichowski; D Gareth Evans; Rosalie E Ferner; Marco Giovannini; Bruce R Korf; Robert Listernick; Kathryn N North; Roger J Packer; Luis F Parada; Juha Peltonen; Vijaya Ramesh; Karlyne M Reilly; John W Risner; Elizabeth K Schorry; Meena Upadhyaya; David H Viskochil; Yuan Zhu; Kim Hunter-Schaedle; Filippo G Giancotti
Journal:  Am J Med Genet A       Date:  2010-12-22       Impact factor: 2.802

2.  Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of Neurofibromatosis type 1.

Authors:  Edwin Jousma; Tilat A Rizvi; Jianqiang Wu; David Janhofer; Eva Dombi; Richard S Dunn; Mi-Ok Kim; Andrea R Masters; David R Jones; Timothy P Cripe; Nancy Ratner
Journal:  Pediatr Blood Cancer       Date:  2015-04-22       Impact factor: 3.167

3.  In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain.

Authors:  Kiran Vasudeva; Yoram Vodovotz; Nabil Azhar; Derek Barclay; Jelena M Janjic; John A Pollock
Journal:  J Neuroimmunol       Date:  2015-04-28       Impact factor: 3.478

Review 4.  Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.

Authors:  Karl Staser; Feng-Chun Yang; David W Clapp
Journal:  Curr Opin Hematol       Date:  2010-07       Impact factor: 3.284

5.  Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.

Authors:  Paola Bargagna-Mohan; Akihiro Ishii; Ling Lei; Daniel Sheehy; Saagar Pandit; Grace Chan; Rashmi Bansal; Royce Mohan
Journal:  J Neurosci Res       Date:  2017-05-10       Impact factor: 4.164

6.  Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.

Authors:  Akihiro Ishii; Miki Furusho; Jeffrey L Dupree; Rashmi Bansal
Journal:  J Neurosci       Date:  2016-06-15       Impact factor: 6.167

7.  Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.

Authors:  Matthew Wood; Melissa Rawe; Gunnar Johansson; Shu Pang; Ryan S Soderquist; Ami V Patel; Sandra Nelson; William Seibel; Nancy Ratner; Yolanda Sanchez
Journal:  Mol Cancer Ther       Date:  2011-06-22       Impact factor: 6.261

8.  Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.

Authors:  Jonathan S Fletcher; Jianqiang Wu; Walter J Jessen; Jay Pundavela; Jacob A Miller; Eva Dombi; Mi-Ok Kim; Tilat A Rizvi; Kashish Chetal; Nathan Salomonis; Nancy Ratner
Journal:  JCI Insight       Date:  2019-02-07

9.  Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.

Authors:  Carlos E Prada; Edwin Jousma; Tilat A Rizvi; Jianqiang Wu; R Scott Dunn; Debra A Mayes; Jose A Cancelas; Eva Dombi; Mi-Ok Kim; Brian L West; Gideon Bollag; Nancy Ratner
Journal:  Acta Neuropathol       Date:  2012-10-26       Impact factor: 17.088

10.  Novel Acellular Scaffold Made from Decellularized Schwann Cell Sheets for Peripheral Nerve Regeneration.

Authors:  Radoslaw Junka; Xiaojun Yu
Journal:  Regen Eng Transl Med       Date:  2015-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.